These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2754807)

  • 1. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; measurement with new synthetic substrate method].
    Ujiie M; Kuroiwa K; Nagasawa T; Sato Y; Kitahara N
    Rinsho Byori; 1989 Apr; Spec No 81():208-13. PubMed ID: 2754807
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; new synthetic chromogenic substrate assays for hemostatic parameters].
    Hiura H; Nishiyama T; Kimura M; Matoba K; Hayashi O; Sasaki M; Ishijima C; Irie Y; Yasuda N
    Rinsho Byori; 1989 Apr; Spec No 81():214-9. PubMed ID: 2754808
    [No Abstract]   [Full Text] [Related]  

  • 3. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ; García Avello A
    Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
    [No Abstract]   [Full Text] [Related]  

  • 7. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs.
    Feldman BF; Madewell BR; O'Neill S
    J Am Vet Med Assoc; 1981 Jul; 179(2):151-4. PubMed ID: 7263467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic efficacy of six plasma proteins in evaluating consumptive coagulopathies. Use of receiver operating characteristic curves to compare antithrombin III, plasminogen, alpha 2-plasmin inhibitor, fibronectin, prothrombin, and protein C.
    Cembrowski GS; Griffin JH; Mosher DF
    Arch Intern Med; 1986 Oct; 146(10):1997-2002. PubMed ID: 3767544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

  • 13. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
    Itoh N
    Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automation in coagulation testing. Clinical applications.
    Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):341-5. PubMed ID: 6606852
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.
    Hayakawa M; Maki M
    Gynecol Obstet Invest; 1988; 26(3):181-90. PubMed ID: 3240888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.